Skip to main content

Inspection visit

Health inspection

APERION CARE DOLTONCMS #1458771 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. Based on interview and record review the facility failed to securely store a resident's injectable medication for 1 of 3 residents (R1) reviewed for medication storage in the sample of 3. The findings include: R1's Face Sheet shows a diagnosis of acute transverse myelitis in demyelinating disease of central nervous system. On 2/21/25 at 10:50 AM, V6 (R1's Family Member) said that she delivered three doses of R1's Enspryng injection that she had delivered to her home from a specialty pharmacy to the facility. V6 said that she received a call from the nurse on 2/7/25 and the nurse said that they could not find her third dose of the injection. V6 said that R1 was sent to the emergency room but was not able to receive the medication but they re-ordered the medication for her and the resident received the dose on 2/12/25. R1's Medication Administration Record (MAR) for January and February shows an order for: Enspryng Subcutaneous Solution Prefilled syringe 120 mg (milligrams)/ML (milliliter)-Inject 120 mg/ml subcutaneously in the afternoon every 2 weeks on Friday for neuromyelitis for 6 weeks. R1's January MAR shows that she received a dose on 1/10/25 and 1/24/25. R1's February MAR shows that she was supposed to get a dose on 2/7/25 but received it on 2/12/25. R1's Nursing Note dated 1/10/25 shows, Approached by [V6] in facility regarding order for Enspryng Three available injections in frig (refrigerator) as per [V6] she brought 3 injections R1's Nursing Note dated 2/7/25 shows, Reached out to [V6] regarding need for Enspryng Subcutaneous Solution Prefilled Syringe. Patient is due for administration this afternoon. None available. Per pharmacy is a specialty medication. Daughter provided last doses. She was made aware of need for medication at this time. On 2/21/25 at 10:39 AM, V3 (Licensed Practical Nurse) said that she was R1's nurse on the day that she needed her third injection. V3 stated that V6 had brought three doses of the injection, and they were put in the medication room refrigerator. V3 stated that they were in separate boxes and had R1's name on them. V3 stated that she administered R1's first and second dose of the medication but the day that her third injection was due, she could not find it in the fridge. V3 stated that she notified V6, V2 (Director of Nursing) and R1's Nurse Practitioner. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 145877 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145877 B. Wing A. Building (X3) DATE SURVEY COMPLETED 02/21/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Aperion Care Dolton 14325 South Blackstone Dolton, IL 60419 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few On 2/21/25 at 12:38 PM, V2 (Director of Nursing) said that she was notified by V3 that she could not find R1's Enspryng injection. V2 stated that she searched the medication room and facility and could not find the injection. V2 stated that she then called V6 and told her that she thinks that the medication got thrown out in error. A Concern Form dated 2/7/25 for R1 shows, Staff reached out to family that a dose of Enspryng injection is missing for [R1] Summary of Pertinent Findings: Substantiated Facility was searched not able to locate. Pt (patient) monitored, sent out to hospital. No adverse reaction. Physician notified On 2/21/25 at 1:59 PM, V1 (Administrator) stated that the facility does not have a policy for when family brings in medications for the resident. The facility's undated Storage of Medication Policy shows, Medications and biologicals are stored safely, securely, and properly, following manufacturer's recommendations or those of the supplier. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145877 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0761GeneralS&S Dpotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

FAQ · About this visit

Common questions about this visit

What happened during the February 21, 2025 survey of APERION CARE DOLTON?

This was a inspection survey of APERION CARE DOLTON on February 21, 2025. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at APERION CARE DOLTON on February 21, 2025?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional princip..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.